Ad
CERS Short Information Cerus Corporation
home / stock / cers / cers short
Short Information | Cerus Corporation (NASDAQ:CERS)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 3,243,971 |
| Total Actual Volume | 29,655,434 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 162,199 |
| Average Short Percentage | 10.59% |
Is there a CERS Short Squeeze or Breakout about to happen?
See the CERS Short Analysis for free Sign up or Login
Powered by Squeeze Report
CERS Twenty Trading Day's Volume to Short Volume Chart
CERS Twenty Trading Day Price Chart
CERS Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 01-17-2025 | $1.84 | $1.79 | $1.84 | $1.745 | 1,057,729 | 157,317 | 14.87% |
| 01-16-2025 | $1.85 | $1.82 | $1.87 | $1.735 | 1,049,462 | 112,081 | 10.68% |
| 01-15-2025 | $1.8 | $1.85 | $1.885 | $1.76 | 2,334,963 | 232,375 | 9.95% |
| 01-14-2025 | $1.71 | $1.73 | $1.78 | $1.69 | 1,830,874 | 281,690 | 15.39% |
| 01-13-2025 | $1.51 | $1.67 | $1.71 | $1.51 | 1,698,386 | 254,569 | 14.99% |
| 01-10-2025 | $1.58 | $1.58 | $1.625 | $1.51 | 2,186,324 | 306,747 | 14.03% |
| 01-08-2025 | $1.64 | $1.63 | $1.66 | $1.6 | 950,876 | 72,664 | 7.64% |
| 01-07-2025 | $1.72 | $1.64 | $1.76 | $1.6201 | 1,677,763 | 187,638 | 11.18% |
| 01-06-2025 | $1.66 | $1.7 | $1.75 | $1.655 | 1,327,886 | 92,003 | 6.93% |
| 01-03-2025 | $1.59 | $1.68 | $1.69 | $1.572 | 1,062,070 | 53,715 | 5.06% |
| 01-02-2025 | $1.53 | $1.57 | $1.58 | $1.51 | 1,592,098 | 167,218 | 10.5% |
| 12-31-2024 | $1.55 | $1.54 | $1.57 | $1.5 | 1,445,652 | 156,843 | 10.85% |
| 12-30-2024 | $1.52 | $1.55 | $1.56 | $1.51 | 1,232,661 | 127,312 | 10.33% |
| 12-27-2024 | $1.65 | $1.56 | $1.65 | $1.52 | 1,796,005 | 270,428 | 15.06% |
| 12-26-2024 | $1.58 | $1.66 | $1.6699 | $1.5511 | 942,636 | 82,061 | 8.71% |
| 12-24-2024 | $1.57 | $1.58 | $1.61 | $1.55 | 565,537 | 40,951 | 7.24% |
| 12-23-2024 | $1.55 | $1.58 | $1.615 | $1.55 | 1,183,232 | 97,977 | 8.28% |
| 12-20-2024 | $1.56 | $1.58 | $1.64 | $1.55 | 2,375,449 | 164,159 | 6.91% |
| 12-19-2024 | $1.62 | $1.58 | $1.63 | $1.55 | 1,196,635 | 143,259 | 11.97% |
| 12-18-2024 | $1.7 | $1.58 | $1.7 | $1.53 | 2,149,196 | 242,964 | 11.3% |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Preliminary Full-Year 2024 Product Revenues Total $180.3 million, 15% Over 2023 Results and Exceed Prior Product Revenue Guidance 2025 Product Revenues Expected to be Between $194-$200 million, Reflecting 8%-11% Growth Year-Over-Year Cerus Corporation (Nasdaq: CERS) today anno...
-
2024-11-04 12:12:22 ET Wall Street favors small caps for their high growth potential, broad sector exposure, and strong performance during economic recoveries, especially as rate cuts lower borrowing costs. Hence, it may be wise to consider buying high-potential small-cap stocks: Owens &a...
-
Third Quarter and First Nine-Month Product Revenue Increased 16% and 18%, respectively from Prior Year Periods Raising Full-Year 2024 Total Product Revenue Guidance to the Range of $177 million to $179 million and INTERCEPT Fibrinogen Complex Revenue Guidance to a range of $9 to $10 milli...